Skip to main content
. 2024 Oct 8;76:102835. doi: 10.1016/j.eclinm.2024.102835

Table 2.

Baseline characteristics of included trials.

Mean age Females Current smoking Hypertension Diabetes mellitus eGFR <60 ml/min/1.73m2 History of stroke or TIA History of ACS Antiplatelet therapy Statin therapy Beta-blocker therapy
CONVINCE 66.3 ± 10.0 30.5% 22.1% 65.4% 22.3% NA 100% 9% 97.5% 93.5% NA
LoDoCo2 65.8 ± 8.6 15.3% 11.8% 50.9% 18.3% 5.5% 4.0% 84.4% 90.9% 94.0% 62.1%
COPS 59.9 ± 10.3 20.8% 34.8% 50.3% 19.0% NA 2.0% 100% 98.6% 98.9% 82.6%
COLCOT 60.6 ± 10.7 19.2% 29.9% 51.0% 20.2% NA 2.6% 100% 98.8% 99.0% 88.9%
Deftereos 63.3 ± 7.0 34.7% 37.8% 48.5% 100% 33.2% NA 31.1% NA NA NA
LoDoCo 67 ± 9.4 11.1% 4.5% NA 30.3% NA NA 23.5% 93.4% 95.1% 66.5%

ACS, acute coronary syndrome. eGFR, estimated glomerular filtration rate. NA, not available. TIA, transient ischaemic attack. History of stroke or TIA was available for 3318 patients, and smoking status was missing for 21 patients in LoDoCo2.